These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27372620)

  • 41. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation.
    Harrington AR; Armstrong EP; Nolan PE; Malone DC
    Stroke; 2013 Jun; 44(6):1676-81. PubMed ID: 23549134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients.
    Deitelzweig S; Luo X; Gupta K; Trocio J; Mardekian J; Curtice T; Lingohr-Smith M; Menges B; Lin J
    Curr Med Res Opin; 2017 Oct; 33(10):1745-1754. PubMed ID: 28849676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embolic stroke during apixaban therapy for left atrial appendage thrombus.
    Ohyagi M; Nakamura K; Watanabe M; Fujigasaki H
    J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):e101-2. PubMed ID: 25620711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients.
    Gibson CM; Smith CB; Davis S; Scalese MJ
    Ann Pharmacother; 2018 Jan; 52(1):54-59. PubMed ID: 28799408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
    Avezum A; Lopes RD; Schulte PJ; Lanas F; Gersh BJ; Hanna M; Pais P; Erol C; Diaz R; Bahit MC; Bartunek J; De Caterina R; Goto S; Ruzyllo W; Zhu J; Granger CB; Alexander JH
    Circulation; 2015 Aug; 132(8):624-32. PubMed ID: 26106009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus--a case report.
    Nseir G; Kwan T; Mandawat M; Feit A; Clark LT
    Angiology; 1999 Mar; 50(3):255-9. PubMed ID: 10088806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP; Halperin JL
    Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.
    Athanasakis K; Karampli E; Tsounis D; Bilitou A; Kyriopoulos J
    Clin Drug Investig; 2015 Nov; 35(11):693-705. PubMed ID: 26385756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series.
    Smetana KS; Dunne J; Parrott K; Davis GA; Collier ACS; Covell M; Smyth S
    J Thromb Thrombolysis; 2017 Nov; 44(4):519-524. PubMed ID: 28948507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
    Guimarães PO; Wojdyla DM; Alexander JH; Thomas L; Alings M; Flaker GC; Al-Khatib SM; Hanna M; Horowitz JD; Wallentin L; Granger CB; Lopes RD
    Int J Cardiol; 2017 Jan; 227():443-449. PubMed ID: 27852444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prompt resolution of an apical left ventricular thrombus in a patient with takotsubo cardiomyopathy.
    Korosoglou G; Haars A; Kuecherer H; Giannitsis E; Katus HA
    Int J Cardiol; 2007 Apr; 116(3):e88-91. PubMed ID: 17125856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombus Formation in Isolated Left Atrial Appendage After Multiple Atrial Fibrillation Ablations Despite Oral Anticoagulation Followed by Percutaneous Appendage Closure.
    Chen S; Schmidt B; Bordignon S; Bologna F; Lindhoff-Last E; Chun KRJ
    JACC Clin Electrophysiol; 2019 Mar; 5(3):398-400. PubMed ID: 30898245
    [No Abstract]   [Full Text] [Related]  

  • 54. Short-Term Risk of Ischemic Stroke After Detection of Left Ventricular Thrombus on Cardiac Magnetic Resonance Imaging.
    Merkler AE; Alakbarli J; Gialdini G; Navi BB; Murthy SB; Goyal P; Kim J; Devereux RB; Safford MM; Iadecola C; Kamel H; Weinsaft JW
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1027-1031. PubMed ID: 30638940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multislice cardiac spiral CT evaluation of atypical hypertrophic cardiomyopathy with a calcified left ventricular thrombus.
    Juergens KU; Wessling J; Fallenberg EM; Mönnig G; Wichter T; Fischbach R
    J Comput Assist Tomogr; 2000; 24(5):688-90. PubMed ID: 11045686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation.
    Själander S; Sjögren V; Renlund H; Norrving B; Själander A
    Thromb Res; 2018 Jul; 167():113-118. PubMed ID: 29803981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial.
    Al-Khatib SM; Thomas L; Wallentin L; Lopes RD; Gersh B; Garcia D; Ezekowitz J; Alings M; Yang H; Alexander JH; Flaker G; Hanna M; Granger CB
    Eur Heart J; 2013 Aug; 34(31):2464-71. PubMed ID: 23594592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
    Douketis J; Bell AD; Eikelboom J; Liew A
    Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry.
    Di Biase L; Briceno DF; Trivedi C; Mohanty S; Gianni C; Burkhardt JD; Mohanty P; Bai R; Gunda S; Horton R; Bailey S; Sanchez JE; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Reddy YM; Zagrodzky J; Hongo R; Beheiry S; Lakkireddy D; Natale A
    Heart Rhythm; 2016 Jun; 13(6):1197-202. PubMed ID: 26994940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
    Kajy M; Shokr M; Ramappa P
    Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.